Olaf Bodamer
Clinical Genetics (M.D.) · Boston, MANPI 1487958146
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,500 of the $4,500 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Takeda Pharmaceuticals U.S.A., Inc..
Across 1 payment — averaging $4500.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$5K
Across 31 payments — averaging $20,571 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$529K
- Mallinckrodt Enterprises LLC$88K
- Mallinckrodt Hospital Products Inc.$10K
- AstraZeneca$6K
- Shire North American Group Inc$5K
What the payments were for
- Consulting fees$4,500100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $4,500 |
How this compares
$4,500 in reported general payments places this provider in the 65th percentile of 33 clinical genetics (m.d.) providers in Massachusetts.
See all clinical genetics (m.d.) providers in Massachusetts →
Other clinical genetics (m.d.) in Boston
- Gerald CoxBoston$475K
- Stephanie SacharowBoston$80K
- Wendy ChungBoston$37K
- Anatalia LabilloyBoston$11K
- Amy KritzerBoston$10K
- Edward NeilanBoston$9K
- Jonathan PickerBoston$8K
- Ingrid HolmBoston$8K
- Huma RanaBoston$5K
- Brian SkotkoBoston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.